Valeant Aims to Compete in Ophthalmology with US$8.7 B Bausch & Lomb Buyout
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 6 (Table of Contents)
Published: 19 Jun-2013
DOI: 10.3833/pdr.v2013.i6.1951 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Valeant Pharmaceuticals International has agreed to acquire Bausch & Lomb (B&L) for approximately US$8...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS